Holen Sie sich die Stockscreener-App
7.7999
2.03%
0.1699
Schlusskurs vom Vortag:
$7.63
Offen:
$7.53
24-Stunden-Volumen:
159.12K
Relative Volume:
0.12
Marktkapitalisierung:
$424.04M
Einnahmen:
$251.46M
Nettoeinkommen (Verlust:
$-892.87M
KGV:
-10.99
EPS:
-0.71
Netto-Cashflow:
$-336.30M
1W Leistung:
-2.81%
1M Leistung:
-6.54%
6M Leistung:
-79.62%
1J Leistung:
-88.13%
1-Tages-Spanne:
$7.53
$7.88
1-Wochen-Bereich:
$7.43
$8.39
52-Wochen-Spanne:
$5.26
$75.20
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Firmenname
Ginkgo Bioworks Holdings Inc
Sektor
Branche
Telefon
(877) 442-5362
Adresse
27 DRYDOCK AVENUE, BOSTON
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-15 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-05-10 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-06-02 | Herabstufung | Goldman | Neutral → Sell |
| 2023-05-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | Eingeleitet | Berenberg | Buy |
| 2022-10-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2022-02-23 | Eingeleitet | Goldman | Neutral |
| 2022-02-01 | Eingeleitet | BofA Securities | Neutral |
| 2022-01-28 | Eingeleitet | BofA Securities | Buy |
| 2022-01-07 | Eingeleitet | BTIG Research | Buy |
| 2021-11-29 | Eingeleitet | Jefferies | Buy |
| 2021-10-13 | Eingeleitet | Raymond James | Outperform |
| 2021-10-12 | Eingeleitet | William Blair | Outperform |
| 2021-09-20 | Eingeleitet | HSBC Securities | Buy |
Alle ansehen
Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation - BioSpace
Vanguard Group Inc's Strategic Reduction in Ginkgo Bioworks Holdings Inc - GuruFocus.com
Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market - MSN
With 48% ownership, Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has piqued the interest of institutional investors - Yahoo Finance
Ginkgo Bioworks (DNA): A Leader in Cell Programming and Genetic Diagnostics - Insider Monkey
10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey
Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know - MSN
Forbes J M & Co. LLP Invests $1.02 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
PFG Investments LLC Invests $1.54 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Major Boston biotech company begins layoffs this week - MSN
Ginkgo Bioworks (NYSE:DNA) Shares Up 5%Here's What Happened - MarketBeat
Equitec Proprietary Markets LLC Has $99,000 Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Sees Significant Growth in Short Interest - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Trading 5.9% HigherStill a Buy? - MarketBeat
Exchange Traded Concepts LLC Has $2.99 Million Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now? - MSN
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Squarepoint Ops LLC - MarketBeat
Algert Global LLC Takes $36,000 Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Receives $4.16 Consensus Target Price from Analysts - MarketBeat
Ginkgo Bioworks Holdings Inc (DNA) Q2 2024 Earnings Call Highlights: Strategic Restructuring ... By GuruFocus - Investing.com Canada
Ginkgo Bioworks executive sells over $10k in company stock By Investing.com - Investing.com Australia
Ginkgo Bioworks exec sells over $2500 in stock By Investing.com - Investing.com Canada
Ginkgo Bioworks executive sells over $10k in company stock - Investing.com
Ginkgo Bioworks exec sells over $2500 in stock - Investing.com
Transforming Healthcare From The Inside Out, Nanorobots Are Revolutionizing Treatment With Precision At The Nanoscale: A Report by TNR, The Niche Research - GlobeNewswire Inc.
Green Alpha Advisors LLC Decreases Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Mackenzie Financial Corp Takes Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Lesaffre strengthens its Research, Development & Innovation (RD&I) with the acquisition of Altar, a company owned by Ginkgo Bioworks - Yahoo Finance
Where are the Opportunities in (DNA) - Stock Traders Daily
Revenues Tell The Story For Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) As Its Stock Soars 33% - Simply Wall St
Virica Biotech and Ginkgo Bioworks Announce Partnership to Accelerate AAV Gene Therapy Manufacturing - Yahoo Finance
Renaissance Technologies LLC Makes New $2.13 Million Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
After Plunging -40.22% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) - MSN
Nanobots in Healthcare Research Report 2024: A $7.1 Billion Market in 2023Global Forecast to 2030 - GlobeNewswire Inc.
Rhumbline Advisers Sells 1,331,930 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Wellington Wealth Strategies LLC. Makes New Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Benjamin F. Edwards & Company Inc. Raises Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Stock Position Lifted by Benjamin F. Edwards & Company Inc. - MarketBeat
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
933,898 Shares in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Purchased by XTX Topco Ltd - MarketBeat
(DNA) Trading Advice - Stock Traders Daily
Novus, Ginkgo Bioworks partner to develop new feed additives - FeedStrategy.com
NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture - PR Newswire
What's Going On With Ginkgo Bioworks Stock This Week? - MSN
Finanzdaten der Ginkgo Bioworks Holdings Inc-Aktie (DNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):